Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of September 14, 2026, OGN trades at $13.64 with a market cap of $3.58B and a P/E ratio of 17.27. OGN moved +0.07% today. Year to date, OGN is +88.40%; over the trailing twelve months it is +27.95%. Its 52-week range spans $5.69 to $17.23. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Organon & Co. (OGN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OGN moved +0.07% today.
| Metric | Value |
|---|---|
| Price | $13.64 |
| Market Cap | $3.58B |
| P/E Ratio | 17.27 |
| EPS | $0.79 |
| Dividend Yield | 0.02% |
| 52-Week High | $17.23 |
| 52-Week Low | $5.69 |
| Volume | 1.49M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.13B |
| Net Income | $209.00M |
| Gross Margin | 52.69% |
OGN analyst coverage data. Average price target: $0.00.